News
Merck MRK announced that the phase III HYPERION study evaluating its pulmonary arterial hypertension (“PAH”) drug, Winrevair ...
Merck’s phase 3 HYPERION study of Winrevair meets primary endpoint in recently diagnosed adults with pulmonary arterial hypertension: Rahway, New Jersey Tuesday, June 24, 2025, ...
Hypertension, also known as high blood pressure, is a condition where the force of blood against your artery walls is ...
Discover the four powerful foods that can help lower blood pressure naturally, as recommended by leading cardiologist Dr.
Intracranial aneurysms are common, and the risk of rupture is influenced by size, location, morphology, and factors such as ...
Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced the receipt of an additional $50.0 ...
MORRISVILLE, N.C., June 23, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, ...
Topline results were announced from a phase 3 study evaluating sotatercept-csrk in recently diagnosed adults with pulmonary arterial hypertension (PAH).
June is Men’s Health Month and a perfect time for men to think about and act on ways to better their heart health. Heart ...
Everyone who is diagnosed with a chronic health condition processes it differently. People might be sad, anxious, or angry.
Salman Khan recently revealed his battle with a brain aneurysm. Neurologist Dr Anil Venkitachalam highlights medical ...
In PAH, 5-year mortality is similar with and without obesity, even though patients with obesity have more comorbidities and worse functional capacity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results